PCVX — Vaxcyte, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1649094 ·
Last close
$65.01
Market Cap
$9.67B
52W High
$90.75
52W Low
$39.87
ADV30
2,557,488
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -302,777,000 | -284,302,000 | 3,138,154,000 | 183,190,000 | 380,212,000 |
| Mar 2026 | 0 | — | -345,850,000 | -320,622,000 | 3,348,308,000 | 260,843,000 | 352,294,000 |
| Dec 2025 | 0 | — | -274,283,000 | -246,507,000 | 3,002,717,000 | 173,959,000 | 317,207,000 |
| Sep 2025 | 0 | — | -242,380,000 | -212,830,000 | 3,171,600,000 | 281,080,000 | 278,718,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-881,233,000
Investing CF
$150,604,000
Financing CF
$606,021,000
CapEx
$-39,835,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-7.05
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,759,871,000
Inventory
—
Receivables
—
ST Investments
$1,303,648,000
EBIT TTM
$-1,165,290,000
Pretax Income TTM
$-1,064,261,000
Interest Exp TTM
—
Analysts
9
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -923,675,000 | -766,628,000 | 3,002,717,000 | 317,207,000 | 2,685,510,000 | -655,577,000 |
| Dec 2024 | 0 | -569,546,000 | -463,927,000 | 3,511,318,000 | 205,499,000 | 3,305,819,000 | -452,627,000 |
| Dec 2023 | 0 | -393,041,000 | -402,266,000 | 1,407,917,000 | 167,449,000 | 1,240,468,000 | -296,790,000 |
| Dec 2022 | 0 | -209,261,000 | -223,485,000 | 1,006,178,000 | 52,565,000 | 953,613,000 | -170,597,000 |
TTM Snapshot
Revenues TTM
$113,393,000
NetIncome TTM
$-946,532,000
OpCashFlow TTM
—
Assets (Latest)
$3,348,308,000
Forward EPS
$-7.22
Max Pain — expiry 2026-10-16
max pain strike: $60.00 · spot: $71.38 · call oi: 18,108 · put oi: 16,198Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $9.69B | $327.30 | — |
| TWST | Twist Bioscience Corp | $10.08B | $152.05 | — |
| RGEN | REPLIGEN CORP | $9.25B | $163.84 | — |
| QGEN | QIAGEN N.V. | $9.20B | $44.53 | — |
| KYMR | Kymera Therapeutics, Inc. | $8.99B | $109.30 | — |
News headlines (Yahoo Finance, 1h cache)
Why Vaxcyte (PCVX) Is Getting Attention Again
2026-10-08 18:15 · Yahoo
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
2026-10-07 02:48 · Yahoo
Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers
2026-10-06 20:34 · Yahoo
As Expected: Vaxcyte Announces $1 Billion Stock and Convertible Raise a Day After Its Phase 3 Win (and Sinks 10%)
2026-10-06 15:31 · Yahoo
Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results
2026-10-06 12:44 · Yahoo
Vaxcyte’s VAX-31 Meets All Primary Endpoints in Pivotal Phase III OPUS-1 Trial
2026-10-06 02:02 · Yahoo
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test
2026-10-05 23:42 · Yahoo
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
2026-10-05 20:28 · Yahoo
PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit ‘Blue-Sky’ Case
2026-10-05 18:37 · Yahoo
Nvidia, Intel, Micron, XP Inc., PTC, Vaxcyte, Western Digital, and More Stocks That Explain Today’s Market
2026-10-05 18:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.